Stakeholders Push for Same Name for Biosimilars in Letter to Hamburg
Proponents of biosimilars carrying the same name as their reference biologic got a boost from a coalition of consumer advocates who penned a letter to FDA Commissioner Margaret Hamburg urging same-name use.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.